Enanta Pharmaceuticals
ENTA
#8126
Rank
S$0.46 B
Marketcap
S$16.01
Share price
3.31%
Change (1 day)
7.50%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: S$0.46 Billion

As of October 2026 Enanta Pharmaceuticals has a market cap of S$0.46 Billion. This makes Enanta Pharmaceuticals the world's 8126th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.46 B-25.34%
2025S$0.62 B260.63%
2024S$0.17 B-33.84%
2023S$0.26 B-79.82%
2022S$1.29 B-37.43%
2021S$2.07 B85.37%
2020S$1.11 B-32.22%
2019S$1.64 B-12.26%
2018S$1.88 B25.28%
2017S$1.50 B62.6%
2016S$0.92 B5.16%
2015S$0.87 B-29.8%
2014S$1.25 B101.4%
2013S$0.62 B

End of Day market cap according to different sources

On Oct 8th, 2026 the market cap of Enanta Pharmaceuticals was reported to be:

S$0.45 Billion
by Nasdaq info icon info icon
S$0.45 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$806.70 B 172,956.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$349.84 B 74,948.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
S$625.54 B 134,093.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$165.43 B 35,388.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$459.94 B 98,568.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$154.62 B 33,071.12%๐Ÿ‡บ๐Ÿ‡ธ USA